Our Novel Cell-Specific Delivery System.
Our innovative, patent-pending CARGO system is a novel cell-specific delivery platform designed to enhance payload delivery capabilities.
This cutting-edge technology allows for unique in vivo delivery of protein or genetic material, addressing the challenges in traditional payload size limitations and specificity in gene therapy treatment.
The CARGO system provides researchers with the flexibility and efficiency needed to optimize therapeutic outcomes while minimizing potential toxicity.
Delivery of RNA, DNA or protein payloads
Versatile, platform-ready drug delivery technology
Unrestricted cargo capacity
Dynamic treatment approaches
Transient or long-term transgene expression
Controlled durability of therapeutic response
High specificity to cell type
Low dose requirements
Non-viral delivery technology
Low immunogenic risk
© Carrigent 2024. All Rights Reserved.
